0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Drug Discovery Informatics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-14V4103
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Discovery Informatics Market Insights and Forecast to 2028
BUY CHAPTERS

Drug Discovery Informatics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14V4103
Report
October 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Discovery Informatics - Market Size

The global market for Drug Discovery Informatics was estimated to be worth US$ 1 million in 2023 and is forecast to a readjusted size of US$ 1 million by 2030 with a CAGR of 9.0% during the forecast period 2024-2030

Drug Discovery Informatics - Market

Drug Discovery Informatics - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Discovery Informatics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Discovery Informatics by region & country, by Type, and by Application.
The Drug Discovery Informatics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Informatics.
Market Segmentation

Scope of Drug Discovery Informatics - Market Report

Report Metric Details
Report Name Drug Discovery Informatics - Market
Forecasted market size in 2030 US$ 1 million
CAGR 9.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Software
  • Services
Segment by Application
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schrödinger, Dassault Systèmes, Charles River Laboratories, Selvita, Certara, GVK Biosciences, Collaborative Drug Discovery, Openeye Scientific Software, IO Informatics, Novo Informatics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Drug Discovery Informatics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Drug Discovery Informatics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Drug Discovery Informatics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Drug Discovery Informatics - Market size in 2030?

Ans: The Drug Discovery Informatics - Market size in 2030 will be US$ 1 million.

Who are the main players in the Drug Discovery Informatics - Market report?

Ans: The main players in the Drug Discovery Informatics - Market are IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schrödinger, Dassault Systèmes, Charles River Laboratories, Selvita, Certara, GVK Biosciences, Collaborative Drug Discovery, Openeye Scientific Software, IO Informatics, Novo Informatics

What are the Application segmentation covered in the Drug Discovery Informatics - Market report?

Ans: The Applications covered in the Drug Discovery Informatics - Market report are Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Others

What are the Type segmentation covered in the Drug Discovery Informatics - Market report?

Ans: The Types covered in the Drug Discovery Informatics - Market report are Software, Services

1 Market Overview
1.1 Drug Discovery Informatics Product Introduction
1.2 Global Drug Discovery Informatics Market Size Forecast
1.3 Drug Discovery Informatics Market Trends & Drivers
1.3.1 Drug Discovery Informatics Industry Trends
1.3.2 Drug Discovery Informatics Market Drivers & Opportunity
1.3.3 Drug Discovery Informatics Market Challenges
1.3.4 Drug Discovery Informatics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Discovery Informatics Players Revenue Ranking (2023)
2.2 Global Drug Discovery Informatics Revenue by Company (2019-2024)
2.3 Key Companies Drug Discovery Informatics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Discovery Informatics Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Discovery Informatics
2.6 Drug Discovery Informatics Market Competitive Analysis
2.6.1 Drug Discovery Informatics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug Discovery Informatics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Informatics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Software
3.1.2 Services
3.2 Global Drug Discovery Informatics Sales Value by Type
3.2.1 Global Drug Discovery Informatics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Discovery Informatics Sales Value, by Type (2019-2030)
3.2.3 Global Drug Discovery Informatics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical & Biotechnology Companies
4.1.2 Contract Research Organizations (CROs)
4.1.3 Others
4.2 Global Drug Discovery Informatics Sales Value by Application
4.2.1 Global Drug Discovery Informatics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Discovery Informatics Sales Value, by Application (2019-2030)
4.2.3 Global Drug Discovery Informatics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug Discovery Informatics Sales Value by Region
5.1.1 Global Drug Discovery Informatics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Discovery Informatics Sales Value by Region (2019-2024)
5.1.3 Global Drug Discovery Informatics Sales Value by Region (2025-2030)
5.1.4 Global Drug Discovery Informatics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug Discovery Informatics Sales Value, 2019-2030
5.2.2 North America Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug Discovery Informatics Sales Value, 2019-2030
5.3.2 Europe Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug Discovery Informatics Sales Value, 2019-2030
5.4.2 Asia Pacific Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug Discovery Informatics Sales Value, 2019-2030
5.5.2 South America Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug Discovery Informatics Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Discovery Informatics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Discovery Informatics Sales Value
6.3 United States
6.3.1 United States Drug Discovery Informatics Sales Value, 2019-2030
6.3.2 United States Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Discovery Informatics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Discovery Informatics Sales Value, 2019-2030
6.4.2 Europe Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Discovery Informatics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Discovery Informatics Sales Value, 2019-2030
6.5.2 China Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Discovery Informatics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Discovery Informatics Sales Value, 2019-2030
6.6.2 Japan Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Discovery Informatics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Discovery Informatics Sales Value, 2019-2030
6.7.2 South Korea Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Discovery Informatics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Discovery Informatics Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Discovery Informatics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Discovery Informatics Sales Value, 2019-2030
6.9.2 India Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Discovery Informatics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 IBM
7.1.1 IBM Profile
7.1.2 IBM Main Business
7.1.3 IBM Drug Discovery Informatics Products, Services and Solutions
7.1.4 IBM Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.1.5 IBM Recent Developments
7.2 Infosys
7.2.1 Infosys Profile
7.2.2 Infosys Main Business
7.2.3 Infosys Drug Discovery Informatics Products, Services and Solutions
7.2.4 Infosys Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.2.5 Infosys Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Drug Discovery Informatics Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.3.5 Perkinelmer Recent Developments
7.4 Perkinelmer
7.4.1 Perkinelmer Profile
7.4.2 Perkinelmer Main Business
7.4.3 Perkinelmer Drug Discovery Informatics Products, Services and Solutions
7.4.4 Perkinelmer Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.4.5 Perkinelmer Recent Developments
7.5 Schrödinger
7.5.1 Schrödinger Profile
7.5.2 Schrödinger Main Business
7.5.3 Schrödinger Drug Discovery Informatics Products, Services and Solutions
7.5.4 Schrödinger Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.5.5 Schrödinger Recent Developments
7.6 Dassault Systèmes
7.6.1 Dassault Systèmes Profile
7.6.2 Dassault Systèmes Main Business
7.6.3 Dassault Systèmes Drug Discovery Informatics Products, Services and Solutions
7.6.4 Dassault Systèmes Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.6.5 Dassault Systèmes Recent Developments
7.7 Charles River Laboratories
7.7.1 Charles River Laboratories Profile
7.7.2 Charles River Laboratories Main Business
7.7.3 Charles River Laboratories Drug Discovery Informatics Products, Services and Solutions
7.7.4 Charles River Laboratories Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.7.5 Charles River Laboratories Recent Developments
7.8 Selvita
7.8.1 Selvita Profile
7.8.2 Selvita Main Business
7.8.3 Selvita Drug Discovery Informatics Products, Services and Solutions
7.8.4 Selvita Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.8.5 Selvita Recent Developments
7.9 Certara
7.9.1 Certara Profile
7.9.2 Certara Main Business
7.9.3 Certara Drug Discovery Informatics Products, Services and Solutions
7.9.4 Certara Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.9.5 Certara Recent Developments
7.10 GVK Biosciences
7.10.1 GVK Biosciences Profile
7.10.2 GVK Biosciences Main Business
7.10.3 GVK Biosciences Drug Discovery Informatics Products, Services and Solutions
7.10.4 GVK Biosciences Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.10.5 GVK Biosciences Recent Developments
7.11 Collaborative Drug Discovery
7.11.1 Collaborative Drug Discovery Profile
7.11.2 Collaborative Drug Discovery Main Business
7.11.3 Collaborative Drug Discovery Drug Discovery Informatics Products, Services and Solutions
7.11.4 Collaborative Drug Discovery Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.11.5 Collaborative Drug Discovery Recent Developments
7.12 Openeye Scientific Software
7.12.1 Openeye Scientific Software Profile
7.12.2 Openeye Scientific Software Main Business
7.12.3 Openeye Scientific Software Drug Discovery Informatics Products, Services and Solutions
7.12.4 Openeye Scientific Software Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.12.5 Openeye Scientific Software Recent Developments
7.13 IO Informatics
7.13.1 IO Informatics Profile
7.13.2 IO Informatics Main Business
7.13.3 IO Informatics Drug Discovery Informatics Products, Services and Solutions
7.13.4 IO Informatics Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.13.5 IO Informatics Recent Developments
7.14 Novo Informatics
7.14.1 Novo Informatics Profile
7.14.2 Novo Informatics Main Business
7.14.3 Novo Informatics Drug Discovery Informatics Products, Services and Solutions
7.14.4 Novo Informatics Drug Discovery Informatics Revenue (US$ Million) & (2019-2024)
7.14.5 Novo Informatics Recent Developments
8 Industry Chain Analysis
8.1 Drug Discovery Informatics Industrial Chain
8.2 Drug Discovery Informatics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Discovery Informatics Sales Model
8.5.2 Sales Channel
8.5.3 Drug Discovery Informatics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Drug Discovery Informatics Market Trends
    Table 2. Drug Discovery Informatics Market Drivers & Opportunity
    Table 3. Drug Discovery Informatics Market Challenges
    Table 4. Drug Discovery Informatics Market Restraints
    Table 5. Global Drug Discovery Informatics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Drug Discovery Informatics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Drug Discovery Informatics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Drug Discovery Informatics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Drug Discovery Informatics
    Table 10. Global Drug Discovery Informatics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Informatics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Drug Discovery Informatics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Drug Discovery Informatics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Drug Discovery Informatics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Drug Discovery Informatics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Drug Discovery Informatics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Drug Discovery Informatics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Drug Discovery Informatics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Drug Discovery Informatics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Drug Discovery Informatics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Drug Discovery Informatics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Drug Discovery Informatics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Drug Discovery Informatics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Drug Discovery Informatics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Drug Discovery Informatics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Drug Discovery Informatics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Drug Discovery Informatics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Drug Discovery Informatics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Drug Discovery Informatics Sales Value, (2025-2030) & (US$ Million)
    Table 31. IBM Basic Information List
    Table 32. IBM Description and Business Overview
    Table 33. IBM Drug Discovery Informatics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Drug Discovery Informatics Business of IBM (2019-2024)
    Table 35. IBM Recent Developments
    Table 36. Infosys Basic Information List
    Table 37. Infosys Description and Business Overview
    Table 38. Infosys Drug Discovery Informatics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Drug Discovery Informatics Business of Infosys (2019-2024)
    Table 40. Infosys Recent Developments
    Table 41. Thermo Fisher Scientific Basic Information List
    Table 42. Thermo Fisher Scientific Description and Business Overview
    Table 43. Thermo Fisher Scientific Drug Discovery Informatics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Drug Discovery Informatics Business of Thermo Fisher Scientific (2019-2024)
    Table 45. Thermo Fisher Scientific Recent Developments
    Table 46. Perkinelmer Basic Information List
    Table 47. Perkinelmer Description and Business Overview
    Table 48. Perkinelmer Drug Discovery Informatics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Drug Discovery Informatics Business of Perkinelmer (2019-2024)
    Table 50. Perkinelmer Recent Developments
    Table 51. Schrödinger Basic Information List
    Table 52. Schrödinger Description and Business Overview
    Table 53. Schrödinger Drug Discovery Informatics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Drug Discovery Informatics Business of Schrödinger (2019-2024)
    Table 55. Schrödinger Recent Developments
    Table 56. Dassault Systèmes Basic Information List
    Table 57. Dassault Systèmes Description and Business Overview
    Table 58. Dassault Systèmes Drug Discovery Informatics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Drug Discovery Informatics Business of Dassault Systèmes (2019-2024)
    Table 60. Dassault Systèmes Recent Developments
    Table 61. Charles River Laboratories Basic Information List
    Table 62. Charles River Laboratories Description and Business Overview
    Table 63. Charles River Laboratories Drug Discovery Informatics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Drug Discovery Informatics Business of Charles River Laboratories (2019-2024)
    Table 65. Charles River Laboratories Recent Developments
    Table 66. Selvita Basic Information List
    Table 67. Selvita Description and Business Overview
    Table 68. Selvita Drug Discovery Informatics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Drug Discovery Informatics Business of Selvita (2019-2024)
    Table 70. Selvita Recent Developments
    Table 71. Certara Basic Information List
    Table 72. Certara Description and Business Overview
    Table 73. Certara Drug Discovery Informatics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Drug Discovery Informatics Business of Certara (2019-2024)
    Table 75. Certara Recent Developments
    Table 76. GVK Biosciences Basic Information List
    Table 77. GVK Biosciences Description and Business Overview
    Table 78. GVK Biosciences Drug Discovery Informatics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Drug Discovery Informatics Business of GVK Biosciences (2019-2024)
    Table 80. GVK Biosciences Recent Developments
    Table 81. Collaborative Drug Discovery Basic Information List
    Table 82. Collaborative Drug Discovery Description and Business Overview
    Table 83. Collaborative Drug Discovery Drug Discovery Informatics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Drug Discovery Informatics Business of Collaborative Drug Discovery (2019-2024)
    Table 85. Collaborative Drug Discovery Recent Developments
    Table 86. Openeye Scientific Software Basic Information List
    Table 87. Openeye Scientific Software Description and Business Overview
    Table 88. Openeye Scientific Software Drug Discovery Informatics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Drug Discovery Informatics Business of Openeye Scientific Software (2019-2024)
    Table 90. Openeye Scientific Software Recent Developments
    Table 91. IO Informatics Basic Information List
    Table 92. IO Informatics Description and Business Overview
    Table 93. IO Informatics Drug Discovery Informatics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Drug Discovery Informatics Business of IO Informatics (2019-2024)
    Table 95. IO Informatics Recent Developments
    Table 96. Novo Informatics Basic Information List
    Table 97. Novo Informatics Description and Business Overview
    Table 98. Novo Informatics Drug Discovery Informatics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Drug Discovery Informatics Business of Novo Informatics (2019-2024)
    Table 100. Novo Informatics Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Drug Discovery Informatics Downstream Customers
    Table 104. Drug Discovery Informatics Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Drug Discovery Informatics Product Picture
    Figure 2. Global Drug Discovery Informatics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Drug Discovery Informatics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Drug Discovery Informatics Report Years Considered
    Figure 5. Global Drug Discovery Informatics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug Discovery Informatics Revenue in 2023
    Figure 7. Drug Discovery Informatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Software Picture
    Figure 9. Services Picture
    Figure 10. Global Drug Discovery Informatics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Drug Discovery Informatics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Pharmaceutical & Biotechnology Companies
    Figure 13. Product Picture of Contract Research Organizations (CROs)
    Figure 14. Product Picture of Others
    Figure 15. Global Drug Discovery Informatics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Drug Discovery Informatics Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Drug Discovery Informatics Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Drug Discovery Informatics Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Drug Discovery Informatics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Drug Discovery Informatics Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Drug Discovery Informatics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Drug Discovery Informatics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Drug Discovery Informatics Sales Value (%), (2019-2030)
    Figure 28. United States Drug Discovery Informatics Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Drug Discovery Informatics Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Drug Discovery Informatics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Drug Discovery Informatics Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Drug Discovery Informatics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Drug Discovery Informatics Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Drug Discovery Informatics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Drug Discovery Informatics Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Drug Discovery Informatics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Drug Discovery Informatics Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Drug Discovery Informatics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Drug Discovery Informatics Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Drug Discovery Informatics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Drug Discovery Informatics Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Drug Discovery Informatics Sales Value by Application (%), 2023 VS 2030
    Figure 49. Drug Discovery Informatics Industrial Chain
    Figure 50. Drug Discovery Informatics Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS